Biopolis Phase II Opens with Strong Interest from Research Institutions and Biomedical Companies
Business space provider Ascendas celebrated the completion of Biopolis Phase II in an Opening Ceremony. Comprising two blocks, named Neuros and Immunos, the Phase II complex releases 37,000 square metres of high quality space to meet the demand for biomedical research and development (R&D) space. Designed and constructed over 18 months, the seven-storey complex has drawn a strong pipeline of interest from biomedical companies. Some of A*STAR's translational research initiatives like the Singapore Immunology Network (SIgN) has committed taking up space to set up research laboratories.
Other news from the department business & finance
These products might interest you

Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.